HopeStage
Back to all studies
RecruitingNCT05048251

Targeted brain stimulation for contamination-related OCD symptoms

About this titleRead the official source — NCT05048251
Device studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
BelmontSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT05048251
Official title
Show the full official title

Individually Targeted Neuromodulation for Contamination-based Obsessive-compulsive Disorder

Recruitment & locations

Currently recruiting

Belmont

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies